Compounded Semaglutide Weight Loss for Westlake
Highland Longevity provides physician-supervised compounded semaglutide for eligible patients from Westlake, with individualized evaluation, DEXA body-composition tracking, and ongoing follow-up. Compounded semaglutide is not FDA-approved; benefits and risks are reviewed during consultation.
Highland's medical weight-loss approach combines physician evaluation, individualized treatment, DEXA body-composition tracking, nutrition support, and follow-up to monitor progress over time.
Physician-led obesity medicine care in Fort WorthWhat is Semaglutide?
Semaglutide is a GLP-1 receptor agonist—the class of medication that transformed obesity medicine. It mimics the satiety hormone your body produces after eating, signaling to your brain that you're full before you overeat.
How options are selected: Highland discusses FDA-approved semaglutide options first when appropriate. A compounded formulation may be considered only for a documented patient-specific clinical need when applicable requirements are met. Compounded semaglutide is not FDA-approved, and approved-product trials do not establish its expected outcomes.
Educational background: Semaglutide as a molecule was originally developed for type 2 diabetes by Novo Nordisk and is sold under the brand names Ozempic® (for diabetes) and Wegovy® (for chronic weight management, introduced for weight management in 2021). Clinical trials of brand-name semaglutide demonstrated average weight loss of 15% over 68 weeks. Highland Longevity does not dispense these brand-name products — these studies inform how the active ingredient is understood, but compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or efficacy.
At Highland Longevity, we pair compounded semaglutide with DEXA body composition analysis and metabolic testing. Why? Because sophisticated patients want to know they're losing fat and preserving muscle—not just watching the scale move.
How Semaglutide Works
Three distinct mechanisms create sustainable appetite control.
Hypothalamic Signaling
Activates GLP-1 receptors in the brain's appetite center, reducing hunger at the neurological level.
Gastric Emptying
Slows stomach emptying, extending satiety for hours after meals and reducing portion sizes naturally.
Reward Pathway
Dampens the brain's reward response to food, eliminating the constant "food noise" that drives overeating.
Clinical Trial Results
Phase 3 STEP trial data—the evidence that matters.
Source: STEP 1 Clinical Trial (N Engl J Med 2021). Results with 2.4mg weekly dose plus lifestyle intervention.
Semaglutide for the Westlake Community
Westlake represents the apex of DFW achievement—from the corporate headquarters at Solana to the estates of Vaquero to the families who chose Westlake Academy for its rigorous IB curriculum. Residents here have built exceptional careers, exceptional businesses, and exceptional lives. But somehow, despite that same drive and discipline, many find that maintaining an optimal body composition becomes increasingly difficult.
The challenge isn't lack of willpower. It's biology. As we age, hormones shift, metabolism slows, and the body fights harder to hold onto fat. Semaglutide changes that equation by working at the neurological level—reducing appetite, quieting food cravings, and making it possible to maintain a caloric deficit without the constant battle.
Highland Longevity is about 15 minutes from Westlake via 114 in the Alliance corridor. The physician-led practice uses clinical history, selected laboratory testing, DEXA body-composition estimates, and resting energy-expenditure estimates to inform individualized care while recognizing the limits of each measurement.
Dosing Schedule
Gradual titration minimizes side effects and optimizes tolerance.
Weeks 1-4
Starting dose
Weeks 5-8
First increase
Weeks 9-12
Therapeutic level
Weeks 13-16
Near target
Week 17+
Full dose
Side Effects & Safety
Most side effects are GI-related, mild, and resolve during the titration phase.
Common Side Effects
- Nausea (typically improves after 2-4 weeks)
- Diarrhea or constipation
- Decreased appetite (the therapeutic effect)
- Mild stomach discomfort
- Fatigue during dose escalation
When to Contact Us
- Severe or persistent nausea/vomiting
- Signs of pancreatitis (severe abdominal pain)
- Vision changes
- Rapid heartbeat
- Signs of allergic reaction
Westlake Semaglutide FAQs
No. Highland discusses FDA-approved options first and limits compounding to documented patient-specific needs. We do not dispense Wegovy®, Ozempic®, or Rybelsus®, which are brand-name semaglutide products manufactured by Novo Nordisk. Compounded semaglutide is prepared by a state-licensed compounding pharmacy under physician supervision. Compounded medications are not FDA-approved.
Highland Longevity offers private, physician-supervised compounded semaglutide 15 minutes from Westlake via 114 West. We're not a high-volume clinic with waiting rooms full of other patients. Expect discrete, unhurried appointments with comprehensive body composition tracking. Highland discusses FDA-approved options first and limits compounding to documented patient-specific needs, not Wegovy or Ozempic.
Yes. Our Full Metabolic Blueprint includes DEXA body composition scanning, RMR metabolic rate testing, comprehensive labs, and physician consultation. This data-driven approach appeals to executives who want measurable results—not just a prescription and a handshake.
Absolutely. We understand Westlake executives have demanding calendars. Appointments are efficient yet thorough, and the injection itself takes 30 seconds once weekly at home. No time-consuming daily regimens or meal prep requirements.
Because muscle is metabolically active tissue. Lose muscle and your metabolism slows—setting you up for weight regain. DEXA estimates changes in fat mass and lean mass; it does not measure muscle directly or guarantee long-term maintenance.
Compounded semaglutide contains the same active molecule (semaglutide) as the brand-name products Wegovy® and Ozempic®. However, compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. The clinical trial data on weight loss outcomes was generated using brand-name semaglutide; Highland prescribes compounded semaglutide, which is sourced from a state-licensed compounding pharmacy under physician supervision. Compounded medications are generally not covered by health insurance — insurance coverage typically applies only to brand-name products such as Wegovy, which Highland Longevity does not dispense.
Ready to Optimize Your Body Composition?
Book a consultation to discuss whether semaglutide fits your goals. We'll review your medical history, assess candidacy, and outline a data-driven protocol.
4801 Golden Triangle Blvd Suite 121, Fort Worth — 15 min from Solana/Vaquero
Compounded medication disclaimer: Highland discusses FDA-approved options first and limits compounding to documented patient-specific needs. We do not dispense Wegovy®, Ozempic®, Rybelsus®, or any other brand-name semaglutide product manufactured by Novo Nordisk.
Compounded semaglutide is prepared by a state-licensed compounding pharmacy under the supervision of our physician. Compounded medications are not FDA-approved. They are permitted under federal law when an FDA-approved product cannot meet the patient's clinical needs, or when the FDA designates a shortage. Your physician will discuss the implications, risks, and benefits of compounded therapy at your consultation.